Clinical trial

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals…

NCT00075816 · Medical College of Wisconsin, Other · Completed

Key facts

NCT number NCT00075816
Title Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
Official title A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell With Marrow Transplantation From Human Leukocyte Antigen (HLA) Compatible Unrelated Donors (BMT CTN #0201)
Lead sponsor Medical College of Wisconsin, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) National Marrow Donor Program
Status Completed
Phase Phase 3
Study type Interventional
Conditions Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
Intervention type Biological
Interventions Allogeneic bone marrow transplantation, Peripheral blood stem cell transplantation
Enrollment 551
Start date Jan 1, 2004
Primary completion Apr 1, 2013
Completion Apr 1, 2014
First posted Jan 13, 2004
Last update posted Jan 4, 2023
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies